Roberto Solari

Biography

 Roberto is a Visiting Professor within the Infection in Airway Disease research group, Respiratory Infections section within the National Heart and Lung Institute, Imperial College London, where he is focused on the discovery of novel targets to allow the development of anti-viral drugs against human Rhinovirus. Previously, he worked at Glaxo (now GlaxoSmithKline), which he joined in 1986, and worked on inflammation and allergy drug discovery. He has since held a number of research posts in industry working from target discovery through to human clinical trials. Most recently, he was Vice President in the Respiratory Therapy Area at GSK leading a group working on the discovery of novel asthma drugs. Roberto has also been involved with the creation of UK companies such as Astex Pharmaceuticals, Lorantis, Chroma Therapeutics and Heptares Therapeutics. Roberto has a BSc and PhD from Nottingham University, and has conducted post-doctoral research at the University of Lausanne and Liverpool University.

Research Interest

 Respiratory Infections